Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Details for Australian Patent Application No. 2008335439 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Young, Christopher; Keshavarz-Shokri, Ali

Agent Baldwins

Pub. Number AU-A-2008335439

PCT Pub. Number WO2009/076141

Priority 61/012,168 07.12.07 US

Filing date 4 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076141 Priority application(s): WO2009/076141

21 October 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335440-Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids

2008335433-Protein extrudates comprising whole grains